Rhumbline Advisers »

Elevation Oncology shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Elevation Oncology (ELEV) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Elevation Oncology

Tip: Access up to 7 years of quarterly data

All positions including Elevation Oncology held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Elevation Oncology by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2024-12-31 $39k 70k 0.56
2024-09-30 $39k 65k 0.60
2024-06-30 $175k 65k 2.70